Glycine Sleep Meta-analysis: What the Evidence Says

Quick Answer

Glycine Sleep Meta-analysis has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• The impact of insomnia disorder extends beyond just broken sleep, notably increasing the risk of mental health issues, interfering with daytime function, and adding to overall health concerns. [Cao ZhiGang (2026); evidence level 1]
• A recent study found that insomnia costs more than $100 billion annually, driven primarily by indirect costs such as reduced workplace productivity, higher healthcare costs, and increased accident risk. [Cao ZhiGang (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For glycine sleep meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Cao ZhiGang (2026). Efficacy of repetitive transcranial magnetic stimulation for insomnia disorder: a systematic review and meta-analysis of randomized controlled trials. DOI: 10.3389/fnins.2026.1816963. PMCID: PMC13265460. PMID: 42305778. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13265460/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.